Genus PLC Logo

Genus PLC

ISIN: GB0002074580 | Ticker: GNS | LEI: 54930022EOITNKSIGH56
Sector: Health CareSub-Industry: Biotechnology
Country: United Kingdom

About Genus PLC

Company Description

Genus PLC is a leading global animal genetics company that specializes in developing high-quality breeding livestock for the agricultural industry. With more than 50 years of experience, Genus has a proven track record of delivering innovative and sustainable solutions to help farmers improve their productivity and profitability.

Genus leverages advanced genetic technology and state-of-the-art research facilities to develop superior breeding livestock that is adaptable to different farming systems and environments. The company's portfolio includes a wide range of products such as dairy and beef cattle, pigs, and sheep that are designed to meet the unique needs of farmers across the world.

Year founded

1933

Served area

Worldwide

Headcount

3,500

Headquarters

Matrix, Basing View, RG21 4DZ Basingstoke – United Kingdom

Financial statements

Download as Excel
Line item in (gbp) 01.07.2021 01.07.2022 01.07.2023
Assets N/A 1,017,900,000.00 1,007,500,000.00
Noncurrent Assets N/A 760,400,000.00 748,500,000.00
Property Plant And Equipment N/A 171,400,000.00 164,400,000.00
Goodwill N/A 111,000,000.00 107,800,000.00
Intangible Assets Other Than Goodwill N/A 72,000,000.00 66,200,000.00
Investment Accounted For Using Equity Method N/A 41,200,000.00 53,500,000.00
Noncurrent Biological Assets N/A 333,700,000.00 318,200,000.00
Other Noncurrent Receivables N/A 8,600,000.00 8,200,000.00
Deferred Tax Assets N/A 10,100,000.00 16,500,000.00
Noncurrent Derivative Financial Assets N/A 2,200,000.00 4,900,000.00
Noncurrent Investments Other Than Investments Accounted For Using Equity Method N/A 10,200,000.00 8,800,000.00
Current Assets N/A 257,500,000.00 259,000,000.00
Inventories N/A 50,900,000.00 61,300,000.00
Trade And Other Current Receivables N/A 129,500,000.00 132,100,000.00
Current Biological Assets N/A 33,100,000.00 23,800,000.00
Cash and cash equivalents 46,000,000.00 38,800,000.00 36,300,000.00
Noncurrent Assets Or Disposal Groups Classified As Held For Sale N/A 200,000.00 0.00
Current Derivative Financial Assets N/A 1,000,000.00 1,500,000.00
Equity -1,500,000.00 572,100,000.00 567,200,000.00
Issued Capital N/A 6,600,000.00 6,600,000.00
Retained Earnings N/A 340,600,000.00 360,600,000.00
Share Premium N/A 179,100,000.00 179,100,000.00
Treasury Shares N/A 100,000.00 100,000.00
Equity Attributable To Owners Of Parent N/A 578,500,000.00 574,900,000.00
Noncontrolling Interests N/A -6,400,000.00 -7,700,000.00
Liabilities N/A 445,800,000.00 440,300,000.00
Noncurrent Liabilities N/A 294,500,000.00 293,100,000.00
Noncurrent Provisions N/A 12,000,000.00 10,300,000.00
Noncurrent Payables N/A 200,000.00 0.00
Deferred Tax Liabilities N/A 60,300,000.00 51,200,000.00
Noncurrent Recognised Liabilities Defined Benefit Plan N/A 8,300,000.00 6,900,000.00
Noncurrent Derivative Financial Liabilities N/A 6,400,000.00 6,200,000.00
Longterm Borrowings N/A 182,100,000.00 196,000,000.00
Current Liabilities N/A 151,300,000.00 147,200,000.00
Current Provisions N/A 1,900,000.00 1,800,000.00
Trade And Other Current Payables N/A 124,700,000.00 122,000,000.00
Current Derivative Financial Liabilities N/A 1,800,000.00 1,800,000.00
Line item in (gbp) 01.07.2021/
01.07.2022
01.07.2022/
01.07.2023
Revenue 593,400,000.00 689,700,000.00
Expense From Sharebased Payment Transactions With Employees 3,700,000.00 6,000,000.00
Amortisation Expense 8,300,000.00 7,700,000.00
Other Gains Losses 0.00 2,700,000.00
Profit Loss From Operating Activities 49,400,000.00 40,500,000.00
Finance Income 400,000.00 1,100,000.00
Finance Costs 6,600,000.00 15,400,000.00
Share Of Profit Loss Of Associates And Joint Ventures Accounted For Using Equity Method 5,200,000.00 10,500,000.00
Profit Loss Before Tax 48,400,000.00 39,400,000.00
Income Tax Expense Continuing Operations 11,700,000.00 7,600,000.00
Profit (loss) 36,700,000.00 31,800,000.00
Profit Loss Attributable To Owners Of Parent 40,900,000.00 33,300,000.00
Profit Loss Attributable To Noncontrolling Interests -4,200,000.00 -1,500,000.00
Line item in (gbp) 01.07.2021 01.07.2022 01.07.2023
Profit (loss) N/A 36,700,000.00 31,800,000.00
Cash Flows From Used In Operating Activities N/A -67,200,000.00 -30,900,000.00
Cash Flows From Losing Control Of Subsidiaries Or Other Businesses Classified As Investing Activities N/A 0.00 3,400,000.00
Cash Flows Used In Obtaining Control Of Subsidiaries Or Other Businesses Classified As Investing Activities N/A 1,000,000.00 400,000.00
Proceeds From Sales Of Property Plant And Equipment Classified As Investing Activities N/A 0.00 2,400,000.00
Purchase Of Property Plant And Equipment Classified As Investing Activities N/A 42,100,000.00 25,900,000.00
Purchase Of Intangible Assets Classified As Investing Activities N/A 8,800,000.00 9,300,000.00
Cash Flows From Used In Investing Activities N/A 34,300,000.00 50,400,000.00
Proceeds From Borrowings Classified As Financing Activities N/A 138,700,000.00 126,800,000.00
Repayments Of Borrowings Classified As Financing Activities N/A 83,900,000.00 111,700,000.00
Payments Of Lease Liabilities Classified As Financing Activities N/A 11,300,000.00 11,100,000.00
Dividends Paid Classified As Financing Activities N/A 20,900,000.00 21,000,000.00
Cash Flows From Used In Financing Activities N/A 21,900,000.00 -18,200,000.00
Increase (decrease) in cash and cash equivalents before effect of exchange rate changes N/A -11,000,000.00 1,300,000.00
Effect Of Exchange Rate Changes On Cash And Cash Equivalents N/A 3,800,000.00 -3,800,000.00
Cash and cash equivalents 46,000,000.00 38,800,000.00 36,300,000.00

Please note that some sums might not add up.

Filings & Publications

2023

Report
Q1
H1
Q3
FY
Consolidated Report
ENG
Corporate Governance Report
Company Presentation
Sustainability Report
Remuneration Report

Insider Trades

Sign up and we will give you access!

Short Interest


Current short interest

Position Holder Short Interest in Percent Date
GLG Partners LP 0.69% 11.07.23
GLG Partners LP 0.71% 23.05.24
JPMorgan Asset Management (UK) Ltd 0.59% 23.05.24
JPMorgan Asset Management (UK) Ltd 0.60% 02.05.24
JPMorgan Asset Management (UK) Ltd 0.54% 29.02.24
GLG Partners LP 0.60% 09.05.24
GLG Partners LP 0.71% 31.08.23
GLG Partners LP 0.52% 29.11.23
GLG Partners LP 0.69% 07.09.23
Total 5.65%

Capital markets information

ISIN

GB0002074580

LEI

54930022EOITNKSIGH56

Sector

Health Care

Industry Group

Pharmaceuticals, Biotechnology & Life Sciences

Industry

Biotechnology

Sub-Industry

Biotechnology

Listed Stock Exchange

London Stock Exchange

Stock Index

FTSE 250

Main Stock Exchange

Contact Investor Relations department

Stay up to date

Keep yourself informed with the most recent updates on FinancialReports, IPOs, product advancements, and other significant news.